Skip to main content
. 2015 Sep 10;5:14000. doi: 10.1038/srep14000

Figure 1.

Figure 1

(A) The Kaplan–Meier curve representing the association between the GSTP1 rs1695 genotypes and recurrence-free survival of patients treated with epirubicin. (B) The Kaplan–Meier curve representing the association between the GSTP1 rs1695 AA vs. AG+GG genotype and recurrence-free survival of patients treated with epirubicin.